February 19, 2023.Reading time 12 minutes.
An interesting question from a reader got me thinking about how, exactly, we track the impacts of Long COVID. Doctors, researchers, and long-haulers themselves have learned a lot about the condition over the last three years. We still don’t have clear estimates of exactly how many people in the U.S. are dealing with this chronic disease, but we’ve come much closer to understanding its impacts than we were when patients first began advocating for themselves in 2020.
Read More
November 6, 2022.Reading time 4 minutes.
Sources and updates for the week of November 6 include Omicron bivalent boosters, a Long COVID clinical trial, an RSV vaccine, and more.
Read More
October 9, 2022.Reading time 4 minutes.
Sources and updates for the week of October 9 include new Long COVID data, updates on RECOVER, Paxlovid utilization, and more.
Read More
May 15, 2022.Reading time 22 minutes.
Over a year after the NIH received $1 billion to study Long COVID, the agency’s flagship study is floundering and frustrating patient advocates. Here are five reasons why Long COVID research is tough in the U.S., taken from my reporting for a recent Grid story.
Read More
October 10, 2021.Reading time 12 minutes.
Though it’s now been well over a year since the first Long COVID patients were infected, there is still so much we don’t know about the condition. For example, we don’t know a very rudimentary number: how many people in the U.S. are struggling with Long COVID. We also don’t have a clear, detailed picture of Long COVID symptoms, or how these symptoms arise from a coronavirus infection, or how they impact the daily lives of Long COVID patients.
Read More
